|
|
ALPS Group Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 10/09/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization64.18 mln
Float48.43 mln
Earnings Date11/30/2026
Relative Strength
21
/ 100
Significantly lagging
Key Fundamentals
EPS-0.02
ROE46.48
ROIC-11.82
ROA-31.49
Interest Cover-1.21
EBITDA, mln-1.50
EV / EBITDA-46.60
EV / EBIT-46.60
Revenue, mln4.86
EV / Revenue14.39
Quote Details
Last
0.37
Change
0.0007 (0.19%)
Open
0.3895
Volume
54,490
Turnover
20,161
Average Volume
56,809
Financial Ratios
Current Ratio0.04
Price / Book8.57
Price / Sales12.89
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-6.33% |
16
/ 100
 |
| 1 Month |
-3.87% |
34
/ 100
 |
| 2 Months |
-36.57% |
12
/ 100
 |
| 6 Months |
-63% |
7
/ 100
 |
|
| |
